Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 442

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 3
Chunk 442
---
 income approach valuation
methodology used for the intangible assets acquired makes use of Level 3 inputs.

Consolidated unaudited pro forma information: 

The following consolidated pro
forma information assumes that the acquisition of BioSymetrics Inc. took place on July 1, 2024 for the statement of operations for the
twelve-month period ended June 30, 2025. These amounts have been estimated after applying the Company’s accounting policies:

    Schedule of consolidated
statements of operations 

    Revenues 
    $663,660 
  
    Net loss 
    $(179,698,700)

The unaudited pro forma results
are presented for informational purposes only and are not necessarily indicative of what the actual results of operations would have been
if the acquisition had occurred at the beginning of the period presented, nor are they indicative of future results of operations.

GEDi Cube Intl Ltd. Acquisition:

On September
28, 2023, the Company, entered into a Stock Purchase Agreement (the “Purchase Agreement”) with GEDi Cube Intl Ltd.,
a private company formed under the laws of England and Wales (“GEDi Cube”) to acquire 100% of the equity interests
of GEDi Cube from its equity holders (the “Sellers”). On September 28, 2023, the Board of Directors of the Company,
and the board of managers of GEDi Cube unanimously approved the Purchase Agreement and on January 25, 2024, the shareholders of the Company
approved the issuance of the shares of Common Stock pursuant to the Purchase Agreement. On February 13, 2024 (the “Closing Date”),
the Company consummated the acquisition of GEDi Cube and the other transactions contemplated by the Stock Purchase Agreement (collectively,
the “Transaction”). As a result of the Transaction, GEDi Cube became a wholly-owned subsidiary of the Company. The Company
believes the acquisition will provide it with access to the nascent field of artificial intelligence and machine learning driven diagnostics,
which was the primary purpose for the acquisition.

Pursuant
to the Stock Purchase Agreement, as of the Closing Date, the Company acquired all the issued and outstanding equity interests of GEDi
Cube owned by the Sellers as of the Closing Date (each, a “GEDi Cube Share” and, collectively, the “GEDi Cube Shares”)
in exchange for which each Seller was entitled to receive (i) as of the Closing Date, such Seller’s pro rata percentage